Zepbound (tirzepatide) stays in your system for about 25 to 30 days after your last injection. The drug has an elimination half-life of approximately 5 days, meaning your body clears half of it roughly every 5 days. After about six half-lives, the amount remaining is negligible.
The 5-Day Half-Life Explained
Every 5 days after your last Zepbound injection, the concentration of tirzepatide in your blood drops by half. So if your last dose produced a certain peak level, five days later you’d have about 50% remaining, ten days later about 25%, and so on. Lilly Medical, the manufacturer, states that tirzepatide should be fully gone from your body in about 30 days after the final dose.
This relatively long half-life is what makes once-weekly dosing possible. The drug stays active in your bloodstream long enough that you don’t need daily injections to maintain consistent levels.
How Your Body Breaks It Down
Tirzepatide is a protein-based molecule, so your body breaks it down the same way it handles other proteins: by snipping the amino acid chain into smaller fragments. These fragments then undergo further chemical processing before being eliminated. About two-thirds of the drug leaves through urine, and the remaining third exits through stool. Notably, intact tirzepatide doesn’t appear in either. By the time the drug reaches your urine or feces, it’s already been broken down into metabolites.
After a single injection, most of the drug is cleared within about 20 days (480 hours). The drug reaches its peak concentration in your blood about 24 hours after injection, though this can range anywhere from 8 to 72 hours depending on the individual.
Steady State vs. Single Dose Clearance
If you’ve been taking Zepbound weekly for several weeks, your body reaches what’s called steady state, where each new dose tops off a level that hasn’t fully cleared from the previous week. This means the total amount of tirzepatide in your system is higher than it would be after a single injection. The 25-to-30-day clearance window still applies from your last dose, but you may notice the drug’s effects (appetite suppression, slower digestion) lingering for several weeks as levels gradually taper.
The drug distributes into a relatively small volume of about 10 to 12 liters, roughly the amount of fluid in your blood and the spaces between your cells. It doesn’t deeply penetrate into fat tissue or muscle in large quantities, which contributes to its predictable clearance timeline.
Effects on Other Medications Can Outlast the Drug
One of Zepbound’s well-known effects is slowing gastric emptying, the rate at which food and pills leave your stomach. Research using physiological modeling found that GLP-1 drugs like tirzepatide can extend gastric emptying time to about 4 hours and slow small intestine transit to around 9 hours. This matters because it changes how your body absorbs other oral medications.
For some drugs, this slower transit actually increases total absorption significantly. Modeling showed that overall exposure increased by 64% for rosuvastatin (a cholesterol medication), 90% for valsartan (a blood pressure medication), and 205% for dabigatran (a blood thinner). Peak concentrations are also delayed, meaning these medications take longer to kick in. If you take oral medications alongside Zepbound, these absorption changes gradually resolve as tirzepatide clears your system, but they won’t disappear overnight after your last injection.
Zepbound and Surgery
Many people searching for how long Zepbound stays in their system are preparing for a surgical procedure. The concern has been that slowed gastric emptying could increase the risk of aspiration (stomach contents entering the lungs) during anesthesia. Updated guidance from the American Society of Anesthesiologists and other medical societies now recommends that most patients can continue taking their GLP-1 medications before elective surgery. Patients considered low risk for delayed stomach emptying don’t need to stop their injections.
Your surgical team will assess your individual risk. If they do ask you to hold a dose, knowing the 5-day half-life helps frame expectations: skipping one weekly injection reduces your levels by roughly half, and skipping two brings you down to about 25% of your typical steady-state concentration.
Factors That May Shift the Timeline
The 5-day half-life and 30-day clearance window are averages drawn from clinical trials. A few factors can nudge your personal timeline in either direction. Your dose matters: higher doses (10 mg or 15 mg) put more drug into your system, so while the half-life stays the same, the absolute amount that needs clearing is greater, and you may feel effects slightly longer. Body weight and composition also play a role, since the drug’s distribution volume varies somewhat between individuals.
Because tirzepatide is broken down by general protein metabolism rather than relying heavily on liver enzymes or kidney filtration of the intact molecule, mild to moderate kidney or liver issues are unlikely to dramatically change how long it stays in your system. The FDA’s clinical pharmacology review did not flag renal or hepatic impairment as factors requiring dose adjustment based on altered clearance.